# Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phosphodiesterase-5-inhibitors-use-and-the-risk-of-alzheimer-s-disease-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Moaz Elsayed Abouelmagd,Maickel AbdelMeseh,Amr Elrosasy,Y Saad,Asmaa Zakria Alnajjar,Mahmoud Eid,Atef Hassan,Abdallah Abbas |
| Citations | 14 |
| DOI | 10.1007/s10072-024-07583-9 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s10072-024-07583-9.pdf |
| OpenAlex ID | https://openalex.org/W4399019271 |
| PMID | 38795271 |
| Type | review |
| Year | 2024 |

## Paper authors

- [Amr Elrosasy](https://scholariq.org/researchers/amr-elrosasy/)

## Paper primary topic

- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)

## Paper topics

- [Phosphodiesterase function and regulation](https://scholariq.org/topics/phosphodiesterase-function-and-regulation/)
- [Sexual function and dysfunction studies](https://scholariq.org/topics/sexual-function-and-dysfunction-studies/)
- [Pharmaceutical Quality and Counterfeiting](https://scholariq.org/topics/pharmaceutical-quality-and-counterfeiting/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.